-
Bangladesh Test cricket reboot delivers in style with historic win
-
Ukraine badminton star: 'How can you feel normal when bombs are falling?'
-
Virgin moves closer to launching Eurostar rival in 2030
-
Rain brings respite as Belgium wrestles massive wildfire
-
Indian marble waste dump becomes unlikely tourist attraction
-
Most stocks rise as US data ease rate fears but fuel economic worries
-
Coach says Australia 'let standards slip' in shock Bangladesh loss
-
India take control of Galle Test as Sri Lanka slump to 99-5
-
Hawaii recovery efforts begin as Lala downgraded, moves west
-
Australia's mushroom murderer appeals conviction
-
Food safety crackdown snares Mumbai's famed restaurants
-
The Nigerian fishing community being eaten up by the Atlantic
-
Trump says US scaling back military drills with Seoul hours before start
-
Kushner to meet Netanyahu after talks with Hamas on Gaza plan
-
Nearly 13,000 displaced after deadly Indonesian quake
-
Photos, memories all that remain for Colombia's bereaved after quake
-
Axe hangs over Australian batters after Darwin 'disaster'
-
Sabalenka squeezes out win on sixth match point in Cincinnati
-
Is this cave in Turkey where Homer wrote 'The Odyssey'?
-
Trump says US scaling back military drills with South Korea hours before start
-
Winning back walls from gangs, artists fill El Salvador's towns with color
-
Jason Arday: UK academic who died amid plagiarism storm
-
Opening arguments expected in Tupac murder trial
-
Sabbath cafe clash lays bare Israel faultlines
-
As machinery removes rubble, hopes for survivors from Colombian quake dwindle
-
SEG Announces 2026 Interim Results
-
Caledonia Mining Corporation Plc: Director Shareholding Notification
-
HM Exploration Commences Borehole & Surface EM Surveys at Lewis Pilley's
-
First Class Metals PLC Announces Application for OTCID Quotation
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - August 17
-
Gold Roth IRA: How It Works, Rules, Taxes, Fees, and What Investors Should Know in 2026 (Guide Released)
-
Top-ranked Scheffler powers to PGA St. Jude Championship victory
-
Trump says US scaling back military drills with South Korea
-
Jacquet scores on Liverpool debut in friendly win over Como
-
Zambia's Hichilema takes early lead in reelection bid
-
Hawaii's Big Island begins recovery efforts as Hurricane Lala downgrades, moves west
-
Sabalenka squeezes out a win on sixth match point in Cincinnati
-
Spidey swings high for third weekend in N. American box office
-
Duplantis dominant, Hunt hits four and Asher-Smith makes history
-
Eagle and late birdie lift Jeeno to LPGA Portland Classic win
-
Spanish soldier dies in Aragon wildfire
-
Duplantis masterclass for fourth Euro pole vault title
-
PSG beaten by Lens in French Champions' Trophy
-
Records for Asher-Smith, Hunt as Britain win 4x100m mixed relay
-
Rybakina, Andreeva race into Cincinnati third round
-
Barcelona reach deal with Man City to sign Rodri
-
Amy Hunt bags fourth Euro gold as Britain win 4x100m mixed relay
-
Misery for Maresca as Man City make dismal start to life after Guardiola
-
Spanish soldier dies in Aragon wildfire: regional leader
-
Strikes kill 19 in Russia and Ukraine
US judges appear skeptical of preserving access to abortion pill
A US federal appeals court panel appeared skeptical on Wednesday of preserving access to a widely used abortion pill.
The three conservative judges pushed back against government arguments that the decision on whether to allow the use of mifepristone should be left to the Food and Drug Administration (FDA), which approved the drug more than 20 years ago.
"We are allowed to look at the FDA just like we're allowed to look at any agency," said Judge James Ho. "That's the role of the courts."
Anti-abortion groups are seeking to have mifepristone banned, claiming despite its long track record that it is unsafe. The case is the latest skirmish in the battle over reproductive rights in the United States.
Ho and one of the other judges on the panel of the New Orleans-based 5th Circuit Court of Appeals were appointed by former president Donald Trump, while the third was also named by a Republican president, George W. Bush.
All three judges seemed unconvinced by arguments by the Justice Department of Democratic President Joe Biden and lawyers for mifepristone manufacturer Danco that the drug should be allowed to remain on the market.
The case stems from a ruling by a conservative US District Court judge in Texas that would have banned mifepristone, which accounts for more than half of the abortions in the United States.
The 5th Circuit Court blocked a ban on the abortion pill, but imposed tough restrictions on access, after which the baton was handed to the Supreme Court, where conservatives wield a 6-3 majority.
The Supreme Court temporarily preserved access to mifepristone, freezing the rulings by the lower courts, and sent the case back to the 5th Circuit.
Jennifer Dalven, director of the ACLU Reproductive Freedom Project, was pessimistic following Wednesday's hearing.
"The arguments today demonstrated in detail that the case has no legal or scientific merit and should have been laughed out of court from the very start," Dalven said.
"Unfortunately, the deck is stacked as the judges hearing this case are well known for their extraordinary hostility to abortion," Dalven said.
Any ruling by the appellate court is likely to eventually reach the Supreme Court, which overturned the constitutional right to abortion 11 months ago.
Since then, more than a dozen states have banned abortion and it has been severely restricted in others.
Mifepristone is one component of a two-drug regimen that can be used through the first 10 weeks of pregnancy.
It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved in 2000.
B.Finley--AMWN